Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by palinc2000on Oct 13, 2022 5:55pm
183 Views
Post# 35023594

Volunteering for Phase 1 TH 1902 trial and difficulty in

Volunteering for Phase 1 TH 1902 trial and difficulty inRecruting.....
The pool for recruiting patients in the trial is made up of patients who have failed all other available options(as far as I know)
I am a witness of a real case where  a dear friend suffering fro a cancer type enumerated in the basket trial and she had been in remission for nearly 7 years after receiving chemo but unfortunately she had a relapse a few months ago and refused any other treatments...She is now in  a palliative care center since this week and her days are counted ......

Patients for the trial have no other  options  but the decision to   volunteer for a clinical trial is not as easy as you would expect ...if it were you would need only a handful of recruiting centers


This is why more recruiting centres are neede
<< Previous
Bullboard Posts
Next >>